---
title: "Norgestimate - Menopausal Flushing"
sidebar: mydoc_sidebar
permalink: db00957-mesh-d019584-1.html
toc: false 
---


Path ID: `DB00957_MESH_D019584_1`
{% include image.html url="images/db00957-mesh-d019584-1.png" file="db00957-mesh-d019584-1.png" alt="db00957-mesh-d019584-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C017576 | Norgestimate | Drug |
| UniProt:P06401 | Progesterone receptor | Protein |
| GO:0050847 | Progesterone receptor signaling pathway | BiologicalProcess |
| UniProt:P03372 | Estrogen receptor | Protein |
| GO:0030520 | Intracellular estrogen receptor signaling pathway | BiologicalProcess |
| MESH:D019584 | Menopausal flushing | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Norgestimate | INCREASES ACTIVITY OF | Progesterone Receptor |
| Progesterone Receptor | POSITIVELY REGULATES | Progesterone Receptor Signaling Pathway |
| Progesterone Receptor Signaling Pathway | TREATS | Menopausal Flushing |
| Norgestimate | INCREASES ACTIVITY OF | Estrogen Receptor |
| Estrogen Receptor | POSITIVELY REGULATES | Intracellular Estrogen Receptor Signaling Pathway |
| Intracellular Estrogen Receptor Signaling Pathway | TREATS | Menopausal Flushing |
|---------|-----------|---------|

Comment: Norgestimate is formulated with ethinylestradiol as a combined oral contraceptive . The norgestimate on it's own is not sufficient for a therapeutic effect.

Reference: 
  - [https://go.drugbank.com/drugs/DB00957](https://go.drugbank.com/drugs/DB00957)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200934/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200934/)
  - [https://en.wikipedia.org/wiki/Norgestimate](https://en.wikipedia.org/wiki/Norgestimate)
